The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tissue Microarray Market Research Report 2025
Synopsis
Tissue Microarray (TMA) refers to the innovative practice of relocating multiple tissues sections from conventional histologic paraffin blocks so that the tissues from multiple samples can be observed on the same slide.It is a novel and useful tool to efficiently analyze gene expression in histological tissues.
The global Tissue Microarray market was valued at US$ 6575.6 million in 2023 and is anticipated to reach US$ 10180 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tissue Microarray, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Microarray.
Report Scope
The Tissue Microarray market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tissue Microarray market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tissue Microarray companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne
Applied Microarrays
Z Biotech
OriGene
BioCat
Bio SB
Creative Bioarray
Abcam
BioIVT
Externautics
Protein Biotechnologies
US Biomax Inc.
Auria Biopankki
Segment by Type
Immunohistochemistry
Fluorescent In-Situ Hybridization
Frozen Tissue Array
Others
Segment by Application
Pharmaceutical and Biotechnological Companies
Research Organization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tissue Microarray companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Tissue Microarray (TMA) refers to the innovative practice of relocating multiple tissues sections from conventional histologic paraffin blocks so that the tissues from multiple samples can be observed on the same slide.It is a novel and useful tool to efficiently analyze gene expression in histological tissues.
The global Tissue Microarray market was valued at US$ 6575.6 million in 2023 and is anticipated to reach US$ 10180 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tissue Microarray, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Microarray.
Report Scope
The Tissue Microarray market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tissue Microarray market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tissue Microarray companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Techne
Applied Microarrays
Z Biotech
OriGene
BioCat
Bio SB
Creative Bioarray
Abcam
BioIVT
Externautics
Protein Biotechnologies
US Biomax Inc.
Auria Biopankki
Segment by Type
Immunohistochemistry
Fluorescent In-Situ Hybridization
Frozen Tissue Array
Others
Segment by Application
Pharmaceutical and Biotechnological Companies
Research Organization
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tissue Microarray companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tissue Microarray Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunohistochemistry
1.2.3 Fluorescent In-Situ Hybridization
1.2.4 Frozen Tissue Array
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tissue Microarray Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnological Companies
1.3.3 Research Organization
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tissue Microarray Market Perspective (2019-2030)
2.2 Tissue Microarray Growth Trends by Region
2.2.1 Global Tissue Microarray Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tissue Microarray Historic Market Size by Region (2019-2024)
2.2.3 Tissue Microarray Forecasted Market Size by Region (2025-2030)
2.3 Tissue Microarray Market Dynamics
2.3.1 Tissue Microarray Industry Trends
2.3.2 Tissue Microarray Market Drivers
2.3.3 Tissue Microarray Market Challenges
2.3.4 Tissue Microarray Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tissue Microarray Players by Revenue
3.1.1 Global Top Tissue Microarray Players by Revenue (2019-2024)
3.1.2 Global Tissue Microarray Revenue Market Share by Players (2019-2024)
3.2 Global Tissue Microarray Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tissue Microarray Revenue
3.4 Global Tissue Microarray Market Concentration Ratio
3.4.1 Global Tissue Microarray Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tissue Microarray Revenue in 2023
3.5 Tissue Microarray Key Players Head office and Area Served
3.6 Key Players Tissue Microarray Product Solution and Service
3.7 Date of Enter into Tissue Microarray Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tissue Microarray Breakdown Data by Type
4.1 Global Tissue Microarray Historic Market Size by Type (2019-2024)
4.2 Global Tissue Microarray Forecasted Market Size by Type (2025-2030)
5 Tissue Microarray Breakdown Data by Application
5.1 Global Tissue Microarray Historic Market Size by Application (2019-2024)
5.2 Global Tissue Microarray Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tissue Microarray Market Size (2019-2030)
6.2 North America Tissue Microarray Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tissue Microarray Market Size by Country (2019-2024)
6.4 North America Tissue Microarray Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tissue Microarray Market Size (2019-2030)
7.2 Europe Tissue Microarray Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tissue Microarray Market Size by Country (2019-2024)
7.4 Europe Tissue Microarray Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tissue Microarray Market Size (2019-2030)
8.2 Asia-Pacific Tissue Microarray Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tissue Microarray Market Size by Region (2019-2024)
8.4 Asia-Pacific Tissue Microarray Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tissue Microarray Market Size (2019-2030)
9.2 Latin America Tissue Microarray Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tissue Microarray Market Size by Country (2019-2024)
9.4 Latin America Tissue Microarray Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tissue Microarray Market Size (2019-2030)
10.2 Middle East & Africa Tissue Microarray Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tissue Microarray Market Size by Country (2019-2024)
10.4 Middle East & Africa Tissue Microarray Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne
11.1.1 Bio-Techne Company Detail
11.1.2 Bio-Techne Business Overview
11.1.3 Bio-Techne Tissue Microarray Introduction
11.1.4 Bio-Techne Revenue in Tissue Microarray Business (2019-2024)
11.1.5 Bio-Techne Recent Development
11.2 Applied Microarrays
11.2.1 Applied Microarrays Company Detail
11.2.2 Applied Microarrays Business Overview
11.2.3 Applied Microarrays Tissue Microarray Introduction
11.2.4 Applied Microarrays Revenue in Tissue Microarray Business (2019-2024)
11.2.5 Applied Microarrays Recent Development
11.3 Z Biotech
11.3.1 Z Biotech Company Detail
11.3.2 Z Biotech Business Overview
11.3.3 Z Biotech Tissue Microarray Introduction
11.3.4 Z Biotech Revenue in Tissue Microarray Business (2019-2024)
11.3.5 Z Biotech Recent Development
11.4 OriGene
11.4.1 OriGene Company Detail
11.4.2 OriGene Business Overview
11.4.3 OriGene Tissue Microarray Introduction
11.4.4 OriGene Revenue in Tissue Microarray Business (2019-2024)
11.4.5 OriGene Recent Development
11.5 BioCat
11.5.1 BioCat Company Detail
11.5.2 BioCat Business Overview
11.5.3 BioCat Tissue Microarray Introduction
11.5.4 BioCat Revenue in Tissue Microarray Business (2019-2024)
11.5.5 BioCat Recent Development
11.6 Bio SB
11.6.1 Bio SB Company Detail
11.6.2 Bio SB Business Overview
11.6.3 Bio SB Tissue Microarray Introduction
11.6.4 Bio SB Revenue in Tissue Microarray Business (2019-2024)
11.6.5 Bio SB Recent Development
11.7 Creative Bioarray
11.7.1 Creative Bioarray Company Detail
11.7.2 Creative Bioarray Business Overview
11.7.3 Creative Bioarray Tissue Microarray Introduction
11.7.4 Creative Bioarray Revenue in Tissue Microarray Business (2019-2024)
11.7.5 Creative Bioarray Recent Development
11.8 Abcam
11.8.1 Abcam Company Detail
11.8.2 Abcam Business Overview
11.8.3 Abcam Tissue Microarray Introduction
11.8.4 Abcam Revenue in Tissue Microarray Business (2019-2024)
11.8.5 Abcam Recent Development
11.9 BioIVT
11.9.1 BioIVT Company Detail
11.9.2 BioIVT Business Overview
11.9.3 BioIVT Tissue Microarray Introduction
11.9.4 BioIVT Revenue in Tissue Microarray Business (2019-2024)
11.9.5 BioIVT Recent Development
11.10 Externautics
11.10.1 Externautics Company Detail
11.10.2 Externautics Business Overview
11.10.3 Externautics Tissue Microarray Introduction
11.10.4 Externautics Revenue in Tissue Microarray Business (2019-2024)
11.10.5 Externautics Recent Development
11.11 Protein Biotechnologies
11.11.1 Protein Biotechnologies Company Detail
11.11.2 Protein Biotechnologies Business Overview
11.11.3 Protein Biotechnologies Tissue Microarray Introduction
11.11.4 Protein Biotechnologies Revenue in Tissue Microarray Business (2019-2024)
11.11.5 Protein Biotechnologies Recent Development
11.12 US Biomax Inc.
11.12.1 US Biomax Inc. Company Detail
11.12.2 US Biomax Inc. Business Overview
11.12.3 US Biomax Inc. Tissue Microarray Introduction
11.12.4 US Biomax Inc. Revenue in Tissue Microarray Business (2019-2024)
11.12.5 US Biomax Inc. Recent Development
11.13 Auria Biopankki
11.13.1 Auria Biopankki Company Detail
11.13.2 Auria Biopankki Business Overview
11.13.3 Auria Biopankki Tissue Microarray Introduction
11.13.4 Auria Biopankki Revenue in Tissue Microarray Business (2019-2024)
11.13.5 Auria Biopankki Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
